Overview

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Status:
Not yet recruiting
Trial end date:
2024-04-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Famotidine